CD68 and neoplasm: Patients whose tumor had CD47high and high tumor-infiltrating CD68+ M (CD68+ Mhigh) and the patients whose tumor had CD47high and high tumor-infiltrating CD163+ M2 (CD163+ M2high) were associated with worse OS (p = 0.003, Fig. 1j; p = 0.005, Fig. 1k), compared to patients with CD47low and to patients with low tumor-infiltrating CD68+ M (CD68+ Mlow), and CD47low and low tumor-infiltrating CD163+ M2 (CD163+ M2low) (p = 0.018, Fig. 1j; p = 0.007, Fig. 1k).